Cargando…
Overall and patient-level comparative effectiveness of dimethyl fumarate and fingolimod: A precision medicine application to the Observatoire Français de la Sclérose en Plaques registry
BACKGROUND: Comparing real-world effectiveness and tolerability of therapies for relapsing-remitting multiple sclerosis is increasingly important, though average treatment effects fail to capture possible treatment effect heterogeneity. With the clinical course of the disease being highly heterogene...
Autores principales: | Simoneau, Gabrielle, Jiang, Xiaotong, Rollot, Fabien, Tian, Lu, Copetti, Massimiliano, Guéry, Matthieu, Ruiz, Marta, Vukusic, Sandra, de Moor, Carl, Pellegrini, Fabio |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
SAGE Publications
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9358343/ https://www.ncbi.nlm.nih.gov/pubmed/35959484 http://dx.doi.org/10.1177/20552173221116591 |
Ejemplares similares
-
Overall and patient-specific comparative effectiveness of dimethyl fumarate versus teriflunomide: A novel approach to precision medicine applied to the German NeuroTrans
Data Multiple Sclerosis Registry
por: Jiang, Xiaotong, et al.
Publicado: (2023) -
Impaired T-cell migration to the CNS under fingolimod and dimethyl fumarate
por: Mathias, Amandine, et al.
Publicado: (2017) -
Characterization of lymphopenia in patients with MS treated with dimethyl fumarate and fingolimod
Publicado: (2018) -
Discontinuation and comparative effectiveness of dimethyl fumarate and fingolimod in 2 centers
por: Vollmer, Brandi, et al.
Publicado: (2018) -
Characterization of lymphopenia in patients with MS treated with dimethyl fumarate and fingolimod
por: Nakhaei-Nejad, Maryam, et al.
Publicado: (2017)